跳至主要内容
临床试验/JPRN-jRCT1030230084
JPRN-jRCT1030230084
招募中
未知

A Study on the Pathophysiological Mechanisms of Reduced Pain Thresholds in Parkinson's Disease with Thermal-Induced Painful Stimuli

Abe Mitsunari0 个研究点目标入组 90 人2023年5月21日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
healthy subjectsParkinson Disease
发起方
Abe Mitsunari
入组人数
90
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年5月21日
结束日期
待定
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
Abe Mitsunari

入排标准

入选标准

  • Parkinson's Disease Arm
  • 1\. Meet the diagnostic criteria of clinically established Parkinson's disease or clinically probable Parkinson disease according to the International Parkinson and Movement Disorder Society diagnostic criteria.
  • 2\. Have a Hoehn \& Yahr stage of 3 or less.
  • 3\. 50 years of age or older.
  • Healthy Elderly Control Arm
  • 1\. 50 years of age or older.
  • 2\. Do not meet the above criteria for Parkinson's disease.
  • Healthy Young Control
  • 1\. 20 years of age or older but less than 50 years.
  • 2\. Do not meet the above criteria for Parkinson's disease.

排除标准

  • 1\. Diagnosis of diseases that cause specific chronic pain, such as osteoarthritis, rheumatoid arthritis, irritable bowel syndrome, fibromyalgia, complex regional pain syndrome, multiple sclerosis, and others.
  • 2\. Presence of chronic pain.
  • 3\. Presence of pain on the day of the visit.
  • 4\. History of major depression or bipolar disorder as defined by DSM\-IV within the past year, or a history of schizophrenia as defined by DSM\-IV in the past.
  • 5\. Presence of parkinsonism.
  • 6\. Presence of skin lesions, such as burns, on the non\-dominant forearm to be stimulated with thermal stimuli.
  • 7\. History of alcohol or drug dependency defined by DSM\-IV within the past two years.
  • 8\. Presence of significant psychiatric symptoms, excitability, or behavioral abnormalities that would make it difficult to comply with the protocol within the past three months.
  • 9\. Presence of systemic severe deseases or unstable conditions.
  • 10\. Presence of other abnormalities that affect cognitive function, such as infections or metabolic disorders.

结局指标

主要结局

未指定

相似试验